FINWIRES · TerminalLIVE
FINWIRES

HKG:2335

2 stories mentioning HKG:2335

Every FINWIRES story that references HKG:2335, newest first.

Asia

Hong Kong Stocks Start Week Marginally Higher; Two Firms File to Go Public in Hong Kong

Hong Kong stocks began the week marginally higher as markets reacted to news of Iran and the U.S. reaching a preliminary deal to end hostilities and reopen the critical Strait of Hormuz.The Hang Seng Index rose by around 124.57 points, or roughly 0.5%, to end at 24,842.67, while the Hang Seng China Enterprises Index finished near flat, inching up 1.31 points, or 0.02%.U.S. President Donald Trump said on Truth Social on Monday that the deal with Iran would keep the Strait of Hormuz permanently open "toll-free" to shipping. He also authorized the immediate removal of the U.S. naval blockade from the key waterway.In local development, Hong Kong's index of industrial production for manufacturing industries increased 3.1% year over year in the first quarter of 2026, but was below the 5.8% expansion recorded in the previous quarter.By major sector, output volume was driven by a 6.6% rise in the metal, computer, electronic and optical products, machinery and equipment industry, while the food, beverages and tobacco sector grew by 2.1%.Elsewhere, the Chamber of Hong Kong Listed Companies urged regulators to further ease listing requirements for innovative companies, saying that lower barriers would help attract more technology firms to raise capital in the city, the South China Morning Post reported, citing comments from its chairman, Chan Ka-keung.In corporate news, two Chinese firms filed to go public in Hong Kong.Shaanxi Micot Pharmaceutical Technology (HKG:2335) said it was seeking HK$1.22 billion via the sale of 58.1 million H shares at an indicative maximum price of HK$21.00 per share. The biotechnology firm is raising funds to advance clinical development of its drug candidates.Meanwhile, Shanghai Seer Intelligent Technology (HKG:6106) is targeting as much as HK$1.07 billion with its offering of 10.5 million H shares at an indicative price of HK$101.60 per share. The robotics company will use proceeds to advance its technology and infrastructure.

Hang SengHKG:2335HKG:6106
Asia

Shaanxi Micot Pharmaceutical Technology Seeks HK$1.2 Billion in Hong Kong IPO

Shaanxi Micot Pharmaceutical Technology (HKG:2335) launched its Hong Kong initial public offering on Monday, seeking to raise up to HK$1.22 billion.The Chinese biotechnology company is offering 58.1 million H shares at an indicative maximum price of HK$21.00 per share, according to a Hong Kong bourse filing.The offering comprises 5.8 million shares for Hong Kong investors and 52.2 million shares for international investors, subject to reallocation and the over-allotment option.The offer price is expected to be determined by June 18, with allocation results due by June 23, ahead of the company's planned trading debut on June 24.Net proceeds, estimated at HK$1.07 billion, will be used primarily to fund the ongoing and planned clinical development and commercialization of Micot Pharmaceutical's core and key product candidates.The company also plans to use the funds for the research and development of other pipeline candidates and technology platforms, as well as for working capital and general corporate purposes.CCB International Capital and China Merchants Securities (HK) are acting as joint sponsors, sponsor-overall coordinators, overall coordinators, joint global coordinators, joint bookrunners, and joint lead managers.

HKG:2335